Remote Jobs at Liquidia Corporation
Find your next remote opportunity · 2 Open Positions
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology.
Liquidia has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Liquidia is also developing L606, an investigational liposomal formulation of treprostinil administered twice-daily with a short-duration next-generation nebulizer, for use in North America.
The subsidiary Liquidia PAH provides for the commercialization of pharmaceutical products to treat pulmonary disease, such as generic Treprostinil Injection.
Executive Director, Clinical Pharmacokinetics
Executive Director leading clinical pharmacokinetics and pharmacometrics strategy for Liquidia’s pulmonary hypertension therapies. Guiding studies, modeling, regulatory submissions, and cross-functional drug development.
Senior Director, Medical Writing
Senior Director leading regulatory and clinical medical writing for Liquidia, a company developing pulmonary arterial hypertension therapies. Guiding global submissions, health authority interactions, and cross-functional document strategy.
No more jobs available.